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Abstract
Background: The purpose of this study is to compare the efficacy of prophylactic antibiotic for
prevention of meningitis in acute traumatic pneumocephalus patients.
Methods: In this prospective, randomized controlled clinical trial, 200 selected head injury patients
with traumatic pneumocephalus are randomly assigned to receive intravenous antibiotics (2 grams
Ceftriaxone twice a day), oral antibiotics (Azithromycin) or placebo for at least 7 days after trauma.
The patients will be followed for one month posttrauma.
Conclusion: The authors hope that this study helps clarifying the effectiveness and indications of
antibiotics in prevention of meningitis in traumatic pneumocephalus after head injury and in specific
subgroup of these patients.
Background
Chemoprophylaxis with antibiotics is both feasible and
desirable for prevention of a potentially serious disease
when specific groups at risk can be defined and when a
safe, effective, and affordable prophylactic agent is availa-
ble [1]. One of such potentially serious diseases is post-
traumatic meningitis. The incidence of posttraumatic
meningitis after head trauma ranges from 0.2 to 17.8 per
cent and increases significantly in the presence of skull
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base fracture, pneumocephalus or cerebrospinal fluid
(CSF) leak [2,3].
Considering the serious complications of the posttrau-
matic meningitis, the idea of chemoprophylaxis with anti-
biotics for prevention of posttraumatic meningitis has
always been considered rational, but the efficacy of pro-
phylactic antibiotic agents in the setting of posttraumatic
CSF leakage is still controversial. The contrasting findings
reported by two large studies in which metaanalyses were
conducted reflect the general disagreement and lack of
sufficient power of the previous studies [4-6].
One possible reason for the inability of the previous stud-
ies to demonstrate the efficacy of prophylactic antibiotics
for prevention of posttraumatic meningitis might have
been inconsideration of those subsets of patients with
specific risk factors [5].
With this concept in mind, the authors tried to clarify
those subgroups at risk in two subsequent studies since
1994. In the first study done in our hospital (Ghodsi M,
Nejat F, Eftekhar B, unpublished data), the efficacy of pro-
phylactic antibiotics in head injury patients with skull
base fracture were studied. Although no statistically signif-
icant differences were found between those with and
without prophylactic antibiotics, 12% of patients with
skull base fractures had pneumocephalus and the inci-
dence of meningitis was considerably higher (20%) in
this subgroup of the head injury patients. In the second
study we selected only patients with posttraumatic pneu-
mocephalus. The overall meningitis rate in head injury
patients with pneumocephalus was 21.5% [5]. That study
again did not approve the prophylactic administration of
ceftriaxone (2 grams daily) in the pneumocephalus
patients. But it showed that CSF rhinorrhea and intracra-
nial hemorrhage might be considered as primary risk fac-
tors and in the absence of them, intradural location of air
and air volume greater than 10 cc as secondary risk factors
for developing meningitis in posttraumatic pneumoceph-
alus patients [5]. Even in those patients with CSF rhinor-
rhea or intracranial hemorrhage, prophylactic ceftriaxone
(2 grams daily) did not prove to be effective on prevention
of meningitis.
Selection of drugs
In posttraumatic meningitis after traumatic pneumoceph-
alus, the microorganisms enter the CSF from the outside
mainly air sinuses. This is the reason why pneumococci
are the major causative microorganisms. In order to pre-
vent posttraumatic meningitis in pneumocephalus
patients, we should either clear the air sinuses from the
potential microorganisms or make the CSF defense strong
enough to control those pathogenic microorganisms that
have passed the blood brain barrier. This simple strategy
has not worked favorably so far. There might be various
reasons. We thought that the dosage of the antibiotics
might have been less than enough due to lack of inflam-
mation of the blood brain barrier. So based on the most
common microorganisms in microbiological studies of
the posttraumatic meningitis it has been decided to
administer antibiotics with full antimeningitic dosage (2
grams Ceftriaxone twice a day) prophylactically.
Another reason for inability of the previous studies to
demonstrate the efficacy of prophylactic antibiotics might
have been lack of enough coverage of the normal flora of
the air sinuses. These sinuses should be considered the
potential source of the secondary infection in majority of
cases. In order to cover these, we selected Azithromycin as
an oral regimen. Penetration of drugs into the cerebrospi-
nal fluid, minimal gastrointestinal side effects, patient tol-
erance and cost-effectiveness of medications were other
important factors in selection of drugs.
In our previous studies meningitis happened almost
always in the first week post trauma, so both regimens are
continued for 7 days.
Objectives
Primary objective
The primary objective of this prospective study is to com-
pare the efficacy of prophylactic antibiotics (either intra-
venous Ceftriaxone 2 grams BID or oral Azithromycin) for
prevention of bacterial meningitis in acute traumatic
pneumocephalus.
Secondary objectives
- To determine the relative frequency of rhinorrhea and
intracranial hemorrhage in each of the IV, O and P groups
- To determine the GCS, age and volume of intracranial air
in each of the IV, O and P groups
- To determine if the volume or location of the air affects
the rate of meningitis.
- To determine the rate of presence and location of the
skull base fracture in each of the IV, O and P groups
- To determine the short term (during the treatment) com-
plications of the administration of the antibiotics in each
of the IV, O and P groups
- To compare the microbiological findings in meningitic
patients among IV, O and P groups
- To determine the frequency of meningitis caused by
resistant bacteria.Trials 2006, 7:2 http://www.trialsjournal.com/content/7/1/2
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Outcome measures
Primary outcome measure
The frequency of bacterial meningitis in IV, O and P
groups
Secondary outcome measures
- The frequency of rhinorrhea, intracranial hemorrhage
and skull base fracture, volume and location of intracra-
nial air in the population study and each of the IV, O and
P groups.
- The mortality rate in study population and each of the
IV, O and P groups.
Methods
Study Population
The study is intended to be a randomized placebo-con-
trolled clinical trial study.
Sample size
The frequency rate of meningitis among our traumatic
pneumocephalus patients was 21.5% (p1). What we
expect to be an intended (or at least acceptable) effect of
the prophylactic antibiotics is 5 %(p2) frequency of men-
ingitis in the patients with antibiotics. To detect this dif-
ference with a sensitivity of 80% and an error probability
of 5%, at least 62 patients per randomization group will
be required using the following formula:
n = 7.84 * [p1(1 - p1) + p2 (1 - p2)]/[p1 - p2]2
Considering only comparing the placebo group with each
one of the antibiotics group, our sample size should be at
least 186 cases. To account for the possibility of loss to fol-
low-up, our estimated sample size is 200 cases.
Ethical approval
This study has been ethically approved by Sina Trauma
and Surgery Research Center, Tehran University.
Inclusion criteria
The entry criterion to this study is traumatic pneumoceph-
alus verified by brain CT scan. The patients should be
older than 15 years old, admitted less than 24 hours after
trauma and we should be able to start the antibiotics in
less than 24 hours after trauma.
Exclusion criteria
Those patients who have received antibiotic therapy for
other reasons within the prior 2 weeks, are on corticoster-
oids or allergic to the specified medications, individuals
with penetrating traumatic brain injury, open skull frac-
tures or operated for any causes, those who are discharged
from hospital with personal consent, all cases with life
threatening lesions including severe brain, abdominal or
vascular injuries and death due to other causes will be
excluded from this study.
Randomization
The randomization list was generated by using the website
Randomization.com http://www.randomization.com.
The permuted block method of randomization for a block
size of three was used. According to this list patients were
allocated to each of the three groups in the trial: intrave-
nous antibiotics, oral antibiotics and placebo.
Blinding
Since providing both the antibiotics and placebo in iden-
tical containers for participating centers is not practically
possible for us, this study is not double-blinded.
Study design
The patients should be observed in the hospital, until
occurrence of meningitis or at least 7 days after trauma. In
the case of concomitant Cerebrospinal Fluid (CSF) leak-
age and need for close observation in the hospital, they
will be hospitalized until recovery from leakage. After dis-
charge the patients will be followed up until one month
after trauma.
The following data is registered: age, sex, time interval
between trauma and admission, time interval between
admission and antibiotic therapy, the cause of trauma,
GCS upon admission, intracranial air volume (at the time
of admission and three days later), intracranial air loca-
tion, presence of CSF rhinorrhea, CSF otorrhea, presence
and location of the radiological signs of skull base frac-
tures, presence and volume of the intracranial hemor-
rhage(at the time of admission and three days later),
presence of meningitis, CSF findings, treatment and com-
plications in the case of meningitis and one month fol-
low-up note.
Intracranial air and hemorrhage volume are calculated in
the CT scan using the formula ABC/2, where A is the great-
est mass diameter by CT, B is the diameter 90° to A, and
C is the approximate number of CT slices with mass mul-
tiplied by the slice thickness. In the case of air in the sub-
arachnoid space, this formula is not easily applicable and
an approximate volume is calculated and determined
whether the volume is less than 10 cc or not [7].
The patients are divided into three groups; with intrave-
nous antibiotics (IV), oral antibiotics (O) and placebo
(P), according to the randomization list. In IV group,
Ceftriaxone 2 grams BID plus oral placebo and in O
group, Azithromycin 500 mg in the first day followed by
250 mg daily plus intravenous placebo for the rest will be
continued for 7 days. Antibiotics should be started in less
than 24 hours after trauma. Since antibiotics may maskPublish with BioMed Central    and   every 
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the clinical presentation of the meningitis, these patients
(IV and O) will remain hospitalized two more days for
close clinical observation. In the case of meningitis,
appropriate antibiotics are continued until patients'
recovery. Corticosteroids should not be prescribed for the
patients for any reason.
The physicians caring for the patients are not blinded to
the regimen that is used.
Intracranial hemorrhages included subarachnoid hemor-
rhage, epidural and subdural hematoma and cerebral con-
tusion or hematoma.
The diagnosis of bacterial meningitis is based upon CSF
findings (increase in leukocyte count, decrease in CSF glu-
cose [<60% of the level simultaneously measured in
blood] increase in the CSF protein > 45 mg/dL and posi-
tive CSF smear or culture) in patients with compatible
clinical findings (fever, headache, nausea and vomiting,
change in the level of consciousness and/or meningismus
not explainable with other causes). Probable meningitis is
defined when positive CSF smear or culture is not availa-
ble. In rare cases with relative contraindications for lum-
bar puncture (accompanying intracranial hemorrhage
and clinically suspected raised intracranial pressure), the
possible diagnosis of meningitis is based upon clinical
findings and ruling out other causes.
Statistical analysis
Intention to treat analysis will be used.
Categorical variables are compared using a chi-square test,
and the Student t-test is used to compare continuous var-
iables between groups. Logistic regression with adjust-
ment for other possible risk factors for meningitis is used
to estimate the odds ratios and 95% confidence intervals.
Discussion
This study can be a major step forward solving one of the
controversial issues in the management of traumatic
pneumocephalus. Considering our circumstances the
design of the study is not double-blinded. This may be
one of the potential shortcomings of the study.
Conclusion
In conclusion, this study is aimed to study the effective-
ness and indications of prophylactic antibiotics in preven-
tion of meningitis in traumatic pneumocephalus patients
after mild head injury.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
BE conceived the trial design, involved in subsequent
adaptations and drafted the manuscript. MG, AH MT, SZS,
VRM, ESK, BE, FN, AY and EK have contributed to adapta-
tions from the original design.
All authors read and approved the final manuscript.
References
1. Schwartz B: Chemoprophylaxis for bacterial infections: princi-
ples of and application to meningococcal infections.  Rev Infect
Dis 1991, 13(Suppl 2):S170-173.
2. Kaufman BA, Tunkel AR, Pryor JC, Dacey RG Jr: Meningitis in the
neurosurgical patient.  Infect Dis Clin North Am 1990, 4:677-701.
3. Helling TS, Evans LL, Fowler DL, Hays LV, Kennedy FR: Infectious
complications in patients with severe head injury.  J Trauma
1988, 28:1575-1577.
4. Villalobos T, Arango C, Kubilis P, Rathore M: Antibiotic prophy-
laxis after basilar skull fractures: a meta-analysis.  Clin Infect Dis
1998, 27:364-369.
5. Eftekhar B, Ghodsi M, Nejat F, Ketabchi E, Esmaeeli B: Prophylactic
administration of ceftriaxone for the prevention of meningi-
tis after traumatic pneumocephalus:results of a clinical trial.
J Neurosurg 2004, 101:757-761.
6. Brodie HA: Prophylactic antibiotics for posttraumatic cere-
brospinal fluid fistulae. A meta-analysis.  Arch Otolaryngol Head
Neck Surg 1997, 123:749-752.
7. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuc-
carello M, Khoury J: The ABCs of measuring intracerebral
hemorrhage volumes.  Stroke 1996, 27:1304-1305.